Administration of JZG reduced the level of biochemical markers (AST, ALT, MDA, LDL-C, TC and TG) in plasma of NASH rats, as well as decreased liver lipids, while liver function and pathological changes of liver tissue were remarkably improved. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.